Settle the questions that hold you up

Yes. The state rules checked on 26 September 2026 allow remote care, but the clinician’s authority and the assessment still matter.

The state rules differed at the check on 26 September 2026. Medical-board guidance rejected a prescription decision based solely on a set questionnaire. The clinician needs a way to come back with questions and collect enough health information for the decision. A form by itself is different from a written exchange that allows follow-up questions.

Ask whether this service uses writing, live conversation or both, and how it meets the rules where you are.

Ask what the assessment includes and what happens if the clinician declines to prescribe. Clarify the fee before the visit.

No. A generic contains the same medicine ingredient as a brand product and has its own approval. A compounded medicine is mixed or made by a pharmacy to meet a particular need. At the 26 September 2026 check, liraglutide had approved generics; compounded preparations had no FDA approval.

At the 26 September 2026 check, the general federal prescribing rules contained no rule that everyone needed a blood test. State rules and the person’s health still affected which checks were needed.

Some medicines have their own FDA safety programs that can require tests. The source behind this answer did not check those programs, so this answer cannot settle testing for a particular product. Ask the prescriber what tests your proposed medicine and your health require.

Use the visit to ask how your health, the proposed purpose, the product and the cost fit together. A comparison page cannot complete that assessment.